Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for chronic unexplained cough
2009-012505-18Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic idiopathic cough (CIC) and gastroesophageal reflux disease (GERD) comparing Esomeprazole arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy of esomeprazole on chronic unexplained cough. Started Jun 2009; status: completed.
02
Drugs
esomeprazole
03
Conditions
chronic idiopathic cough (CIC)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2009-012505-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012505-18.